Top Abstract Purchase Related
Home
>
Node
>
Subnode

Clinical management of dialysis-related carnitine deficiency: three case studies

Lindberg, J.; Sadler, R.; Slowik, M.

Nephrology News and Issues 17(5): 73

2003

ISSN/ISBN: 0896-1263
PMID: 12715628
Document Number: 552827
Though future clinical trials will help establish better-defined guidelines for L-carnitine as a therapeutic agent, clearly there are subsets of dialysis patients who can benefit from L-carnitine therapy, as evidenced by the case studies described in this article. In each of these cases, L-carnitine significantly improved the patient's quality of life by increasing muscle strength and energy levels, increasing hematocrit, minimizing intradialytic morbidities that interfere with dialysis prescription, or improving cardiac function. Given the limited side effects, a trial of L-carnitine with ongoing evaluation of beneficial effect is a reasonable therapeutic option for chronic dialysis patients with clinical conditions related to DCD.

Document emailed within 1 workday
Secure & encrypted payments

De Prà, M.; Oberti, F.; De Benedittis, A. 1990: Changes in carnitine metabolism. A case report about probable partial deficiency of muscle carnitine palmitoyltransferase La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 12(4): 397-403
Von Petrykowski, W.; Ketelsen, U.P.; Schmidt-Sommerfield, E.; Penn, D.; Sawicka, E.; Struck, E.; Lehnert, W.; Haap, K.; Strassburg, H.M. 1985: Primary systemic carnitine deficiency under successful therapy: clinical, biochemical, ultrahistochemical and renal clearance studies Clinical Neuropathology 4(2): 63-71
Morand, P.; Despert, F.; Carrier, H.N.; Saudubray, B.M.; Fardeau, M.; Romieux, B.; Fauchier, C.; Combe, P. 1979: Lipidic myopathy with severe cardiomyopathy caused by a generalized carnitine deficiency. Favourable course during carnitine hydrochloride treatment Archives des Maladies du Coeur et des Vaisseaux 72(5): 536-544
Scholte, H.R.; Rodrigues Pereira, R.; Busch, H.F.; Jennekens, F.G.; Luyt-Houwen, I.E.; Vaandrager-Verduin, M.H. 1989: Carnitine deficiency, mitochondrial dysfunction and the heart. Identical defect of oxidative phosphorylation in muscle mitochondria in cardiomyopathy due to carnitine loss and in Duchenne muscular dystrophy Wiener Klinische Wochenschrift 101(1): 12-17
Kobayashi, J.; Ichimura, M.; Sugie, Y.; Sugie, H.; Igarashi, Y. 1986: A case of phosphoglucomutase deficiency with decreased muscle and serum carnitine No to Hattatsu 18(4): 310-315
Kawecka-Jaszcz, K.; Królikowski, T.; Olszanecka, A. 2002: Dilated cardiomyopathy complicating primary carnitine deficiency. A case report Kardiologia Polska 57(12): 551-559
Nakamura, J.; Koh, N.; Sakakibara, F.; Hamada, Y.; Hara, T.; Sasaki, H.; Chaya, S.; Komori, T.; Nakashima, E.; Naruse, K.; Kato, K.; Takeuchi, N.; Kasuya, Y.; Hotta, N. 1998: Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats Journal of Pharmacology and Experimental Therapeutics 287(3): 897-902
Berkel, A.I.; Loos, M.; Sanal, O.; Mauff, G.; Güngen, Y.; Ors, U.; Ersoy, F.; Yegin, O. 1979: Clinical and immunological studies in a case of selective complete C1q deficiency Clinical and Experimental Immunology 38(1): 52-63
Giordano, C.; Perrotti, G. 1979: Clinical studies of the effects of treatment with a combination of carnitine and cobamamide in infantile anorexia La Clinica Terapeutica 88(1): 51-60
Keane, W.F.; Everett, E.D.; Golper, T.A.; Gokal, R.; Halstenson, C.; Kawaguchi, Y.; Riella, M.; Vas, S.; Verbrugh, H.A. 1993: Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis 13(1): 14-28
Winchester, J.F. 2000: L-carnitine and peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(Suppl 2): S150-S153
Shihabi, Z.K.; Oles, K.S.; McCormick, C.P.; Penry, J.K. 1992: Serum and tissue carnitine assay based on dialysis Clinical Chemistry 38(8 Pt 1): 1414-1417
Angelini, C.; Lücke, S.; Cantarutti, F. 1976: Syndrome of carnitine deficiency Acta Neurologica 31(1): 84-89
Vaisrub, S. 1973: Carnitine deficiency myopathy JAMA 225(2): 165-166
Stavem, K.; Bjerke, G.; Skullerud, K.; Bøhmer, T. 1994: Rhabdomyolysis in carnitine palmitoyltransferase deficiency Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(20): 2398-2399
Aguilera, A.; Bajo, M.A.; del Peso, G.; Diez, J.J.; Codoceo, R.; Rebollo, F.; Mariano, M.; Selgas, R. 2002: True deficiency of antioxidant vitamins e and a in dialysis patients. Relationship with clinical patterns of atherosclerosis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 206-211
Osá, E.; Simonsen, H. 2004: Carnitine transporter deficiency in two Faeroese children Ugeskrift for Laeger 166(50): 4612-4613
Steinman, T.I.; Nissenson, A.R.; Glassock, R.J.; Dickmeyer, J.; Mattern, W.D.; Parker, T.F.; Hull, A.R. 2003: L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they? Nephrology News and Issues 17(5): 28-30 32-4 36 Passim
Delacour, J.L.; Wagschal, G.; Floriot, C.; Daoudal, P.; Guyon, B.; Ory, J.P. 1987: Acute respiratory insufficiency and carnitine palmitoyltransferase deficiency Presse Medicale 16(14): 683-684
Argov, Z.; DiMauro, S. 1983: Recurrent exertional myalgia and myoglobinuria due to carnitine palmityltransferase deficiency Israel Journal of Medical Sciences 19(6): 552-554